Stockreport

Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart [Yahoo! Finance]

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report
PDF validate biological activity – – Abiprubart development in Sjogren's Disease fully funded through Phase 3 – – Company expects to remain cash flow positive on an annual b [Read more]